With over 20 years of experience in the life sciences sector, Shelly has held key financial leadership roles in both public and private companies.  She currently serves as Vice President of Finance at Acurion and Senior Vice President of Finance at Tempo Therapeutics.  Previously Shelly was Vice President of Finance at Viracta Therapeutics and Conatus Pharmaceuticals.  Earlier in her career, she was Chief Financial Officer at Althea Technologies.  Shelly also served as an auditor at Ernst & Young.  She holds a Bachelor of Science degree from the University of Northern Colorado.